Enabling in-house comprehensive genomic profiling from tissue and liquid biopsy samples with TruSight™ Oncology 500.
Comprehensive Genomic Profiling (CGP) offers a streamlined, faster method for gaining insights into the genomic underpinnings of cancer. With proven solutions and world-class support, the Illumina TruSight Oncology 500 (TSO500) portfolio is ready to enable your CGP efforts.

Download this brochure to learn more about the TSO500 streamlined portfolio. This brochure also covers the following topics:
© 2026 Msifoworld. All rights reserved.
Join our email list to get the exclusive
unpublished content right in your inbox.